We are thrilled to announce that Universiti Malaya Medical Centre (UMMC), under the leadership of Assoc. Prof. Dr. Rozita Binti Abdul Malik, has been recognized as one of the global top enrollers for Part 1 of the OPERA-1 clinical trial, a pivotal study in advancing breast cancer treatment.
With the support of Study Coordinator Toh Yok Yong, UMMC successfully fulfilled its patient recruitment target within the stipulated timeline, contributing significantly to the trial’s success. This achievement underscores UMMC’s dedication to excellence in clinical research and its commitment to improving outcomes for breast cancer patients worldwide.
We extend our heartfelt gratitude to Assoc. Prof. Dr. Rozita, Toh Yok Yong, and the entire UMMC team for their exceptional efforts. Your contributions have been invaluable in driving the success of the OPERA-1 trial.